For reference, tesamorelin's FDA label dose alone is 2 mg/day (or 1.28 mg/day for the EGRIFTA WR formulation), and ipamorelin has been studied around 100-300 mcg per dose
The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, Tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes
Frequently Asked Questions Is IVY RX legitimate
In a 2023 study investigating GHS-based treatments for neurodegenerative diseases like amyotrophic lateral sclerosis (ALS), hexarelin was one of two GHSs chosen for experimentation
This suggests that researchers can expect similar outcomes from either compound when using equivalent dosing approaches
Its antioxidant properties protect against oxidative damage, contributing to longevity and well-being